PROK · ProKidney Corp. Class A Ordinary Shares
What's happening
- PROK is up 0.35% today, trading at $1.45. — Live quote
- Volume today (45,912) is well below its 3-month average of 1,362,180. (Finnhub fundamentals)
- Reports earnings on 2026-11-09, 18 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-0.15 actual vs. $-0.14 estimated (-4.5%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Aggregate ratings for 2026-10-01 (14 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
Earnings Trends (Quarterly EPS Actual vs Estimate)
Valuation Measures & Ratios
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 4, filed 2026-08-20; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -32.1% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is -10288.4%. Finnhub fundamentals ↗
- Trailing 52-week price return is -56.2%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on PROK
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Operating income | -$48.4M | -$44.9M | -$38.5M | -$39.7M | -$41.4M | -$49.0M | -$43.1M | -$40.1M |
| Net income | -$28.4M | -$20.0M | -$16.5M | -$16.6M | -$16.7M | -$17.9M | -$12.5M | -$9.5M |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $249.0M | $292.8M | $335.6M | $351.6M | $372.1M | $406.1M | $441.1M | $474.8M |
| Total liabilities | $26.2M | $29.7M | $34.8M | $33.3M | $32.7M | $36.1M | $39.4M | $31.3M |
| Stockholders' equity | -$883.5M | -$1.02B | -$1.01B | -$1.01B | -$1.00B | -$998.6M | -$995.0M | -$979.7M |
| Total current assets | $189.8M | $234.9M | $280.7M | $300.0M | $324.4M | $359.7M | $395.9M | $430.2M |
| Total current liabilities | $22.7M | $25.9M | $30.7M | $29.1M | $28.3M | $32.8M | $36.2M | $25.2M |
| Cash & equivalents | $74.9M | $101.9M | $108.5M | $95.3M | $84.9M | $97.8M | $99.1M | $108.1M |
| Other current assets | $772.0K | $1.8M | $2.8M | $110.0K | $546.0K | $62.0K | $80.0K | $1.0M |
| Property, plant & equipment | $56.0M | $54.4M | $51.2M | $47.8M | $43.5M | $43.3M | $42.2M | $38.5M |
| Intangible assets | — | — | — | — | — | — | — | — |
| Accounts payable | $1.6M | $2.6M | $940.0K | $1.9M | $2.4M | $3.1M | $3.6M | $2.9M |
| Accrued liabilities | $20.0M | $22.2M | $28.7M | $26.1M | $24.9M | $27.6M | $31.1M | $21.3M |
| Common stock & paid-in capital | — | — | — | — | — | — | — | — |
| Retained earnings | -$1.32B | -$1.29B | -$1.27B | -$1.25B | -$1.23B | -$1.22B | -$1.20B | -$1.18B |
| Accumulated other comprehensive income (loss) | -$34.0K | -$53.0K | $56.0K | $74.0K | $30.0K | $75.0K | $130.0K | $321.0K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$40.4M | -$41.7M | -$32.5M | -$26.6M | -$31.4M | -$29.6M | -$24.2M | -$29.2M |
| Investing cash flow | $12.8M | $34.8M | $28.1M | $29.0M | $18.6M | $28.3M | $15.1M | -$81.6M |
| Financing cash flow | $541.0K | $215.0K | $17.6M | $8.0M | -$14.0K | -$12.0K | $123.0K | $4.5M |
| Free cash flow | -$44.2M | -$45.5M | -$38.3M | -$31.8M | -$34.5M | -$30.7M | -$49.7M | -$31.6M |
| Capital expenditures | $3.8M | $3.8M | $5.8M | $5.2M | $3.1M | $1.1M | $25.5M | $2.4M |
| Depreciation & amortization | $1.7M | $1.7M | $1.8M | $1.7M | $1.5M | $1.6M | $1.6M | $1.5M |
| Share-based compensation | $5.6M | $4.9M | $5.7M | $6.7M | $6.5M | $6.4M | $6.9M | $6.9M |
| Purchases of investments | $32.0M | $44.8M | $40.4M | $78.5M | $42.7M | $55.4M | $46.7M | $194.4M |
| Share repurchases | — | — | $0 | — | — | — | $0 | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating income | -$165.0M | -$183.7M | -$151.5M | -$153.0M | -$55.1M |
| Net income | -$69.0M | -$61.2M | -$35.5M | — | -$55.1M |
| EPS (diluted) | — | — | — | $-0.23 | — |
| EPS (basic) | — | — | — | $-0.23 | — |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $335.6M | $441.1M | $420.6M | $518.0M | $40.3M |
| Total liabilities | $34.8M | $39.4M | $29.2M | $13.1M | $13.4M |
| Stockholders' equity | -$1.01B | -$995.0M | -$1.10B | -$1.10B | $26.9M |
| Total current assets | $280.7M | $395.9M | $374.1M | $504.7M | $27.3M |
| Total current liabilities | $30.7M | $36.2M | $25.0M | $10.9M | $12.3M |
| Cash & equivalents | $108.5M | $99.1M | $60.6M | $490.3M | $20.6M |
| Other current assets | $2.8M | $80.0K | $9.0K | $1.4M | $25.0K |
| Property, plant & equipment | $51.2M | $42.2M | $42.1M | $10.7M | $11.4M |
| Intangible assets | — | — | $0 | $213.0K | $428.0K |
| Accounts payable | $940.0K | $3.6M | $5.1M | $3.0M | $2.8M |
| Accrued liabilities | $28.7M | $31.1M | $17.7M | $7.3M | $9.2M |
| Retained earnings | -$1.27B | -$1.20B | -$1.14B | -$1.10B | -$161.5M |
| Accumulated other comprehensive income (loss) | $56.0K | $130.0K | $130.0K | $0 | — |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$120.1M | -$126.4M | -$90.1M | -$77.1M | -$50.3M |
| Investing cash flow | $104.0M | $20.4M | -$330.0M | -$1.7M | -$5.2M |
| Financing cash flow | $25.6M | $144.4M | -$9.6M | $548.5M | $71.5M |
| Free cash flow | -$135.3M | -$155.9M | -$124.3M | -$78.9M | -$55.5M |
| Capital expenditures | $15.2M | $29.5M | $34.2M | $1.8M | $5.2M |
| Depreciation & amortization | $6.6M | $5.4M | $3.9M | $3.0M | $2.0M |
| Share-based compensation | $25.3M | $29.4M | $30.8M | $74.5M | $699.0K |
| Purchases of investments | $217.1M | $324.0M | $471.6M | $0 | $0 |
| Share repurchases | $0 | $0 | $9.5M | $0 | $0 |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding PROK as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-06-03 to 2026-08-20
Recent transactions
- Insiders have net sold 757,164 shares over the last 182 days, across 0 purchases and 6 sales.
- Most recent: Pereira Brian JG (Reporting person) — Open market sale of 222,948 shares on 2026-08-20.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Pereira Brian JG | Reporting person | Open market sale | 2026-08-20 | 222,948 |
| Girolamo Todd C | Chief Legal Officer | Derivative conversion | 2026-06-12 | 163,857 |
| Control Empresarial de Capitales S.A. de C.V. | Reporting person | Derivative conversion | 2026-04-28 | 63,118,645 |
| Weber Darin J. | Chief Regulatory Officer | Open market sale | 2025-07-08 | 103,480 |
| Legorreta Pablo G. | Reporting person | Derivative conversion | 2025-06-03 | 3,823,996 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-20 | Pereira Brian JG | Reporting person | Open market sale | 222,948 | $1.42 |
| 2026-08-20 | Pereira Brian JG | Reporting person | Open market sale | 27,052 | $1.42 |
| 2026-08-19 | Pereira Brian JG | Reporting person | Open market sale | 222,949 | $1.44 |
| 2026-08-19 | Pereira Brian JG | Reporting person | Open market sale | 27,051 | $1.44 |
| 2026-08-18 | Pereira Brian JG | Reporting person | Open market sale | 229,338 | $1.37 |
| 2026-08-18 | Pereira Brian JG | Reporting person | Open market sale | 27,826 | $1.37 |
| 2026-08-04 | Pereira Brian JG | Reporting person | Derivative conversion | 81,929 | $0.00 |
| 2026-08-04 | Pereira Brian JG | Reporting person | Derivative conversion | 675,235 | $0.00 |
| 2026-06-12 | Girolamo Todd C | Chief Legal Officer | Derivative conversion | 163,857 | $0.00 |
| 2026-04-28 | Control Empresarial de Capitales S.A. de C.V. | Reporting person | Derivative conversion | 63,118,645 | $0.00 |
| 2025-11-13 | Pereira Brian JG | Reporting person | Open market sale | 447,803 | $2.37 |
| 2025-11-13 | Pereira Brian JG | Reporting person | Open market sale | 54,333 | $2.37 |
| 2025-11-12 | Pereira Brian JG | Reporting person | Open market sale | 227,431 | $2.72 |
| 2025-11-12 | Pereira Brian JG | Reporting person | Open market sale | 27,595 | $2.72 |
| 2025-07-08 | Weber Darin J. | Chief Regulatory Officer | Open market sale | 103,480 | $3.02 |
| 2025-06-03 | Legorreta Pablo G. | Reporting person | Derivative conversion | 3,823,996 | $0.00 |
| 2025-06-03 | Legorreta Pablo G. | Reporting person | Other acquisition/disposition | 3,823,996 | $0.00 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-21 23:25 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-08-20 | 4 | 2026-08-18 | View on SEC.gov → |
| 2026-08-10 | 8-K | 2026-08-10 | View on SEC.gov → |
| 2026-08-10 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-06 | 4 | 2026-08-04 | View on SEC.gov → |
| 2026-07-06 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-06-15 | 4 | 2026-06-12 | View on SEC.gov → |
| 2026-05-29 | 4 | 2026-05-28 | View on SEC.gov → |
| 2026-05-29 | 4 | 2026-05-28 | View on SEC.gov → |
| 2026-05-29 | 4 | 2026-05-28 | View on SEC.gov → |
| 2026-05-29 | 4 | 2026-05-28 | View on SEC.gov → |
| 2026-05-29 | 4 | 2026-05-28 | View on SEC.gov → |
| 2026-05-29 | 4 | 2026-05-28 | View on SEC.gov → |
Recent news
Headlines about PROK (ProKidney Corp. Class A Ordinary Shares). Links open the publisher — we don’t host full articles.
-
PROK Nov 2026 2.000 call (PROK261120C00002000) stock price, news, quote and history
Yahoo Finance UK · 2026-10-18 -
ProKidney Corp. (PROK) Slides 8.59% to $1.33 as Shares Test Lower Support - Jurik MA
https://www.siam.in/ · 2026-10-18 -
Is ProKidney (NASDAQ:PROK) In A Good Position To Deliver On Growth Plans?
Moomoo · 2026-10-18 -
ProKidney(ナスダック:PROK)は成長計画の達成に向けて好位置にあるか?
Moomoo · 2026-10-18 -
PROK Jan 2028 2.000 put (PROK280121P00002000) interactive stock chart
Yahoo Finance UK · 2026-10-16 -
ProKidney Announces Eight Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2026
Yahoo Finance · 2026-10-02 -
ProKidney (PROK) Nears A Pivotal Kidney Therapy Verdict
Yahoo Finance · 2026-09-11 -
ProKidney: Do-Or-Die Phase 3 Meets A Dwindling Balance Sheet (Rating Downgrade)
Seeking Alpha · 2026-08-14
No headlines in this category right now — try “All”.